SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-078984
Filing Date
2008-04-10
Accepted
2008-04-10 16:04:34
Documents
4
Period of Report
2008-04-08
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 16544
2 FORM OF WARRANT dex41.htm EX-4.1 79478
3 SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 231327
4 PRESS RELEASE dex991.htm EX-99.1 7556
  Complete submission text file 0001193125-08-078984.txt   336430
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 08750096
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1